What is Koning?
Koning Health operates at the intersection of medical technology and oncology diagnostics. The company is the developer of the Koning Vera Breast CT (KBCT), a sophisticated imaging solution that provides high-resolution 3D visualization of breast tissue without the discomfort of traditional compression methods. By leveraging a robust portfolio of over 120 patents, Koning is effectively disrupting the standard of care in breast imaging. Its market position is defined by a commitment to clinical precision and patient-centric design, catering to a global network of healthcare providers and diagnostic centers seeking to improve early-stage cancer detection rates.
How much funding has Koning raised?
Koning has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Koning
PPP
Public-Private Partnership
What's next for Koning?
Following this major strategic investment, Koning is expected to prioritize the global scaling of its KBCT technology. The late-stage funding context suggests a shift toward aggressive market penetration and the expansion of its international distribution channels. Future strategic initiatives will likely focus on clinical validation studies to further solidify the efficacy of its 3D imaging, alongside operational scaling to meet the growing demand for non-compressive diagnostic alternatives. As the company matures, it remains a key player to watch in the medical imaging sector, particularly as it seeks to integrate its technology into mainstream clinical workflows worldwide.
See full Koning company page
